Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ankyrin repeat and EF-hand domain-containing protein 1 (ANKEF1) is a protein encoded by the ANKEF1 gene that features both ankyrin repeats, commonly involved in protein–protein interactions, and an EF-hand domain, typically involved in calcium binding[2][4]. ANKEF1 has been identified in multiple studies as playing roles in vertebrate biology, including cilia formation and function, cell adhesion, embryonic morphogenesis, and possibly cellular signaling[2][3]. High expression is noted in testis and brain, consistent with a critical role in sperm motility—ANKRD5/ANKEF1 knockout mice exhibit reduced sperm motility and male infertility due to disruption of the axonemal nexin–dynein regulatory complex (N-DRC) essential for flagellar movement[1]. Additional studies link ANKEF1 to cancer risk pathways, particularly in the context of transgenerational mammary cancer risk in mice exposed to a high-fat maternal diet[2]. Mutations or disruption of ANKEF1 are also associated with hereditary deafness[4]. Studies in zebrafish and Xenopus models implicate ANKEF1 in embryonic development, cell protrusion, and tissue morphogenesis; downregulation produces defects such as spina bifida and shortened body axis[2][3]. Despite its biological importance, ANKEF1 is not currently recognized as a direct therapeutic target, and there are no known approved drugs or small molecules that act on it.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ankyrin repeat and EF-hand domain-containing protein 1 (ANKEF1).